Related Experiment Video
Updated: Dec 10, 2025

A Novel In Vitro Wound Healing Assay to Evaluate Cell Migration
Published on: March 17, 2018
An Update on Antimicrobial Peptides (AMPs) and Their Delivery Strategies for Wound Infections
Viorica Patrulea1,2, Gerrit Borchard1,2, Olivier Jordan1,2
1Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, 1 Rue Michel Servet, 1211 Geneva, Switzerland.
Abstract:
Bacterial infections occur when wound healing fails to reach the final stage of healing, which is usually hindered by the presence of different pathogens. Different topical antimicrobial agents are used to inhibit bacterial growth due to antibiotic failure in reaching the infected site, which is accompanied very often by increased drug resistance and other side effects. In this review, we focus on antimicrobial peptides (AMPs), especially those with a high potential of efficacy against multidrug-resistant and biofilm-forming bacteria and fungi present in wound infections. Currently, different AMPs undergo preclinical and clinical phase to combat infection-related diseases. AMP dendrimers (AMPDs) have been mentioned as potent microbial agents. Various AMP delivery strategies that are used to combat infection and modulate the healing rate-such as polymers, scaffolds, films and wound dressings, and organic and inorganic nanoparticles-have been discussed as well. New technologies such as Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)-associated protein (CRISPR-Cas) are taken into consideration as potential future tools for AMP delivery in skin therapy.
Insights
Antimicrobial peptides (AMPs) show promise for treating wound infections, especially those resistant to antibiotics. This review explores AMPs, AMP dendrimers (AMPDs), and novel delivery systems for enhanced wound healing.
Area of Science:
- Biomedical Science
- Wound Healing Research
- Antimicrobial Therapy
Background:
- Bacterial wound infections impede healing, often resisting conventional topical antimicrobials due to poor drug penetration, resistance, and side effects.
- Multidrug-resistant and biofilm-forming pathogens pose significant challenges in wound infection management.
- There is a critical need for effective antimicrobial strategies to overcome these limitations and promote wound healing.
Purpose of the Study:
- To review the potential of antimicrobial peptides (AMPs) in combating wound infections, particularly those caused by multidrug-resistant and biofilm-forming bacteria and fungi.
- To discuss antimicrobial peptide dendrimers (AMPDs) as potent antimicrobial agents.
- To explore various AMP delivery strategies and emerging technologies for skin therapy.
Main Methods:
- Literature review focusing on antimicrobial peptides, AMP dendrimers, and their applications in wound infection treatment.
- Analysis of current preclinical and clinical studies involving AMPs.
- Examination of diverse AMP delivery systems, including polymers, scaffolds, films, wound dressings, and nanoparticles.
- Consideration of advanced technologies like CRISPR-Cas for AMP delivery.
Main Results:
- Antimicrobial peptides (AMPs) demonstrate high efficacy against multidrug-resistant and biofilm-forming pathogens relevant to wound infections.
- Antimicrobial peptide dendrimers (AMPDs) are identified as potent antimicrobial agents with significant therapeutic potential.
- Various delivery strategies, including nanoparticles and advanced wound dressings, enhance AMP efficacy and modulate healing rates.
- Emerging technologies like CRISPR-Cas offer novel avenues for targeted AMP delivery in skin therapy.
Conclusions:
- Antimicrobial peptides (AMPs) represent a promising therapeutic class for managing complex wound infections.
- Innovative delivery systems and technologies are crucial for optimizing AMP efficacy and overcoming challenges in wound healing.
- Further research and clinical translation of AMP-based therapies and delivery strategies are warranted for improved patient outcomes.
More Related Videos
Related Concept Videos
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Gene Regulation in Microbial Communities: Quorum Sensing
Biological Methods for Microbial Control
Phases of Wound Repair
Formation of Blood Clot
In case of deep injuries, trauma to blood vessels results in blood loss. In the meantime, phospholipids released from the ruptured endothelial cellular membrane are converted into arachidonic...
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Bacterial Signaling

